Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence

Nutrients. 2021 Jun 6;13(6):1949. doi: 10.3390/nu13061949.

Abstract

Primary open-angle glaucoma (POAG) remains a leading cause of irreversible blindness globally. Recent evidence further substantiates sustained oxidative stress, and compromised antioxidant defenses are key drivers in the onset of glaucomatous neurodegeneration. Overwhelming oxidative injury is likely attributed to compounding mitochondrial dysfunction that worsens with age-related processes, causing aberrant formation of free radical species. Thus, a compromised systemic antioxidant capacity exacerbates further oxidative insult in glaucoma, leading to apoptosis, neuroinflammation, and subsequent tissue injury. The purpose of this systematic review is to investigate the neuroprotective benefits of the macular carotenoids lutein, zeaxanthin, and meso-zeaxanthin on glaucomatous neurodegeneration for the purpose of adjunctive nutraceutical treatment in glaucoma. A comprehensive literature search was conducted in three databases (PubMed, Cochrane Library, and Web of Science) and 20 records were identified for screening. Lutein demonstrated enhanced neuroprotection on retinal ganglion cell survival and preserved synaptic activity. In clinical studies, a protective trend was seen with greater dietary consumption of carotenoids and risk of glaucoma, while greater carotenoid levels in macular pigment were largely associated with improved visual performance in glaucomatous eyes. The data suggest that carotenoid vitamin therapy exerts synergic neuroprotective benefits and has the capacity to serve adjunctive therapy in the management of glaucoma.

Keywords: MPOD; carotenoids; glaucoma; lutein; macular pigment; macular pigment optical density; meso-zeaxanthin; primary open-angle glaucoma; retinal neurodegeneration; zeaxanthin.

Publication types

  • Systematic Review

MeSH terms

  • Antioxidants / administration & dosage*
  • Carotenoids / administration & dosage*
  • Dietary Supplements*
  • Glaucoma, Open-Angle / metabolism
  • Glaucoma, Open-Angle / therapy*
  • Humans
  • Lutein / administration & dosage
  • Macular Pigment / metabolism
  • Oxidative Stress / drug effects
  • Visual Acuity / drug effects
  • Zeaxanthins / administration & dosage

Substances

  • Antioxidants
  • Macular Pigment
  • Zeaxanthins
  • Carotenoids
  • meso-zeaxanthin
  • Lutein